Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPACA: Laparoscopic Antibiotic Lavage in Complicated Appendicitis
NCT06841003Phase 3Recruiting
- Sponsor
- Spaarne Gasthuis
- Start
- Feb 2025
- Primary completion
- Jun 2027
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of gentamicin and clindamycin in appendicitis (2 arms), sponsored by Spaarne Gasthuis. Primary endpoint: Incidence of intra-abdominal abscess at 30 days. Started Feb 2025; status: recruiting.
02
Drugs
gentamicinclindamycin
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT06841003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841003.